As of 2026-07-02, the Intrinsic Value of Genpact Ltd (G) is 47.25 USD. This Genpact valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 27.50 USD, the upside of Genpact Ltd is 71.80%.
The range of the Intrinsic Value is 39.36 - 58.89 USD
Based on its market price of 27.50 USD and our intrinsic valuation, Genpact Ltd (G) is undervalued by 71.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 39.36 - 58.89 | 47.25 | 71.8% |
| DCF (Growth 10y) | 50.50 - 73.93 | 60.00 | 118.2% |
| DCF (EBITDA 5y) | 32.20 - 41.24 | 35.72 | 29.9% |
| DCF (EBITDA 10y) | 43.25 - 55.45 | 48.23 | 75.4% |
| Fair Value | 55.81 - 55.81 | 55.81 | 102.95% |
| P/E | 22.72 - 29.40 | 27.41 | -0.3% |
| EV/EBITDA | 18.35 - 29.80 | 24.33 | -11.5% |
| EPV | 34.68 - 45.34 | 40.01 | 45.5% |
| DDM - Stable | 22.56 - 42.54 | 32.55 | 18.4% |
| DDM - Multi | 31.25 - 46.43 | 37.40 | 36.0% |
| Market Cap (mil) | 4,661.52 |
| Beta | 0.55 |
| Outstanding shares (mil) | 169.51 |
| Enterprise Value (mil) | 5,636.87 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.27% |
| Cost of Debt | 4.31% |
| WACC | 7.81% |